Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Jackson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Oncogene|January 16, 2013
The mutant p53 mouse as a pre-clinical modelJ G Jackson, G Lozano
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|November 2, 1999
IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cellsJ G Jackson, D Yee
AJR. American Journal of Roentgenology|November 1, 1987
Permanent eyeliner and MR imagingJ G Jackson, J D Acker
British Journal of Cancer|July 21, 2011
Lymphosarcoma in the Ovary in Young African Girls in NigeriaD S Brew, J G Jackson
Journal of the Tennessee Medical Association|January 1, 1987
Asymptomatic anterior mediastinal massJ G Jackson, S L Gammill
Heart & Lung : the Journal of Critical Care|September 1, 1988
Evaluation of bruises and areas of induration after two techniques of subcutaneous heparin injectionJ B Wooldridge, J G Jackson
Journal of the Tennessee Medical Association|July 1, 1986
Right lower quadrant pain and tenderness: appendiceal abscess with appendicolithJ G Jackson, S L Gammill
Dimensions in Health Service|September 1, 1974
Study shows quick source for bacteria: foes among the flowersJ S McGovern, J G Jackson
The Journal of Biological Chemistry|May 23, 1998
Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cellsJ G Jackson, M F White, D Yee
Clinical Imaging|August 1, 1990
Renal oncocytoma: report of a case with bilateral multifocal oncocytomasG O Mead, L R Thomas, J G Jackson
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Oncogene|January 16, 2013
The mutant p53 mouse as a pre-clinical modelJ G Jackson, G Lozano
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|November 2, 1999
IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cellsJ G Jackson, D Yee
AJR. American Journal of Roentgenology|November 1, 1987
Permanent eyeliner and MR imagingJ G Jackson, J D Acker
British Journal of Cancer|July 21, 2011
Lymphosarcoma in the Ovary in Young African Girls in NigeriaD S Brew, J G Jackson
Journal of the Tennessee Medical Association|January 1, 1987
Asymptomatic anterior mediastinal massJ G Jackson, S L Gammill
Heart & Lung : the Journal of Critical Care|September 1, 1988
Evaluation of bruises and areas of induration after two techniques of subcutaneous heparin injectionJ B Wooldridge, J G Jackson
Journal of the Tennessee Medical Association|July 1, 1986
Right lower quadrant pain and tenderness: appendiceal abscess with appendicolithJ G Jackson, S L Gammill
Dimensions in Health Service|September 1, 1974
Study shows quick source for bacteria: foes among the flowersJ S McGovern, J G Jackson
The Journal of Biological Chemistry|May 23, 1998
Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cellsJ G Jackson, M F White, D Yee
Clinical Imaging|August 1, 1990
Renal oncocytoma: report of a case with bilateral multifocal oncocytomasG O Mead, L R Thomas, J G Jackson
Pageof 5